skip to Main Content

May 17, 2022
Treatment Action Group Mourns Urvashi Vaid, Celebrates Her Life and Legacy
Statement / Press
Treatment Action Group (TAG) today mourns the premature loss of transformative LGBTQ and AIDS activist Urvashi Vaid, formerly executive director of the National Gay and Lesbian Task Force (now the National LGBTQ Task Force) at the height of the U.S. AIDS crisis in the late 1980s and early 1990s, and…

May 16, 2022
U.S. Government Funded Research Brings Shorter Tuberculosis Treatment Regimens to New York City
Statement / Press
We applaud the New York City Department of Health and Mental Hygiene (DoHMH) for its leadership as one of the first TB programs in the U.S. and globally to introduce a new four-month regimen for the treatment of drug-susceptible tuberculosis (TB).

May 4, 2022
From Evidence to Action: Community-led Monitoring for Access to TB Screening and Diagnostic Testing
Webinar / Presentation
Treatment Action Group (TAG) and the Coalition of Women Living with HIV and AIDS (COWLHA) hosted this webinar on how community-led monitoring (CLM) can be used to assess, document, and improve the availability, accessibility, acceptability, and quality of local TB screening and diagnostic services.

April 13, 2022
TAG Submission to WHO Public Hearing Regarding a New International Instrument on Pandemic Preparedness and Response
Letter / Comment
At the first of these two public hearings TAG submitted the following statement with six reasons why the new international instrument must explicitly acknowledge the right to science as a central guiding framework.

April 7, 2022
Community-led Monitoring for Access to Tuberculosis Screening and Diagnostic Testing
People at risk of tuberculosis (TB) have a right to TB screening and diagnostic testing in accordance with the standard of care recommended by the World Health Organization (WHO). Yet, many countries with high burdens of TB have limited uptake of WHO-recommended tools, such as rapid molecular tests and urine-LAM…

March 22, 2022
CROI 2022 TB Round Up
Statement / Press
Treatment Action Group welcomes the tuberculosis (TB) data reported at the 2022 Conference on Retroviruses and Opportunistic Infections (CROI). This is a summary of major findings — and TAG’s take on them.

March 17, 2022
The Right to Prevent TB
It’s now easier than ever to prevent TB before it develops into active disease or spreads within communities.

February 23, 2022
Mourning Paul Farmer, Honoring His Legacy
Statement / Press
TAG’s staff and board of directors are filled with grief at the premature death of Dr. Paul Farmer, who illuminated and changed our world with his combination of passion, intelligence, solidarity with the poor, and determined will for social justice.

February 18, 2022
European Commitments to TB R&D Investments: Promises Made to Be Broken?
In this brief, TAG outlines the pathway the EU can take to scale up support for TB R&D, and advance the many European-sponsored TB vaccine candidates currently in the development pipeline.

February 15, 2022
Submission to the Office of the High Commissioner for Human Rights Input to HRC resolution 47/17
Letter / Comment
On February 9, TAG submitted this testimony to the Office of the High Commission for Human Rights (OHCHR) to inform its upcoming report to the Human Rights Council (HRC) on ‘human rights in the context of HIV/AIDS’ (HRC resolution 47/17).

December 16, 2021
2021 TAG Update
As we look forward to an end of an extremely challenging year—and past four years—we reflect on the remarkable resilience and impact of TAG, even and especially in these dark times.

December 9, 2021
2021 Report on TB Research Funding Trends
TB R&D Report
TAG’s latest report on global funding for TB research and development (R&D), published in collaboration with the Stop TB Partnership, presents new data on TB R&D funding in 2020 and analyzes trends in funding since 2005.

November 4, 2021
Hepatitis C and Tuberculosis Long-Acting Medicines: Analysis of Patenting Trends and Implications for Access
This new report offers recommendations to ensure access to long-acting technologies throughout the research and development process.

October 26, 2021
An Activist’s Guide to Shorter Treatment for Drug-Sensitive Tuberculosis
After a decades-long wait, shorter treatment for drug-sensitive tuberculosis (TB) for adults and children is finally possible. Two landmark clinical trials (S31/A5349 and SHINE) have demonstrated that adults, adolescents, and some children can be cured of TB in as little as four months.

October 14, 2021
Statement from TAG’s TB Project on Today’s WHO Global TB Report
Statement / Press
Today’s Global TB Report from WHO confirms our worst expectations for how COVID-19 has set back the global TB response. The pandemic has reversed an entire generation of progress. The first year-on-year increase in TB deaths since 2005 is devastating.

Back To Top